Annual Working Capital
$883.12 M
-$207.12 M-19.00%
December 31, 2023
Summary
- As of February 8, 2025, NTLA annual working capital is $883.12 million, with the most recent change of -$207.12 million (-19.00%) on December 31, 2023.
- During the last 3 years, NTLA annual working capital has risen by +$330.86 million (+59.91%).
- NTLA annual working capital is now -19.00% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
NTLA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$605.22 M
-$46.90 M-7.19%
September 30, 2024
Summary
- As of February 8, 2025, NTLA quarterly working capital is $605.22 million, with the most recent change of -$46.90 million (-7.19%) on September 30, 2024.
- Over the past year, NTLA quarterly working capital has dropped by -$196.32 million (-24.49%).
- NTLA quarterly working capital is now -44.49% below its all-time high of $1.09 billion, reached on December 31, 2022.
Performance
NTLA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NTLA Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.0% | -24.5% |
| 3 y3 years | +59.9% | -15.6% |
| 5 y5 years | +210.5% | +134.2% |
NTLA Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -19.0% | +37.2% | -44.5% | at low |
| 5 y | 5-year | -19.0% | +247.9% | -44.5% | +158.1% |
| alltime | all time | -19.0% | >+9999.0% | -44.5% | +1000.9% |
Intellia Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $605.22 M(-7.2%) |
| Jun 2024 | - | $652.12 M(-17.0%) |
| Mar 2024 | - | $786.13 M(-11.0%) |
| Dec 2023 | $883.12 M(-19.0%) | $883.12 M(+10.2%) |
| Sep 2023 | - | $801.54 M(-4.6%) |
| Jun 2023 | - | $839.76 M(-2.4%) |
| Mar 2023 | - | $860.29 M(-21.1%) |
| Dec 2022 | $1.09 B(+69.4%) | $1.09 B(+49.8%) |
| Sep 2022 | - | $727.82 M(-5.7%) |
| Jun 2022 | - | $771.67 M(+3.0%) |
| Mar 2022 | - | $749.26 M(+16.4%) |
| Dec 2021 | $643.47 M(+16.5%) | $643.47 M(-10.3%) |
| Sep 2021 | - | $717.21 M(+50.9%) |
| Jun 2021 | - | $475.44 M(-12.0%) |
| Mar 2021 | - | $540.38 M(-2.2%) |
| Dec 2020 | $552.26 M | $552.26 M(+53.2%) |
| Sep 2020 | - | $360.38 M(-6.9%) |
| Jun 2020 | - | $387.23 M(+65.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $234.46 M(-7.6%) |
| Dec 2019 | $253.85 M(-10.7%) | $253.85 M(-1.8%) |
| Sep 2019 | - | $258.42 M(-3.8%) |
| Jun 2019 | - | $268.67 M(+1.6%) |
| Mar 2019 | - | $264.46 M(-7.0%) |
| Dec 2018 | $284.40 M(-12.1%) | $284.40 M(+4.2%) |
| Sep 2018 | - | $272.91 M(-6.7%) |
| Jun 2018 | - | $292.46 M(-6.3%) |
| Mar 2018 | - | $312.14 M(-3.5%) |
| Dec 2017 | $323.47 M(+29.1%) | $323.47 M(+59.1%) |
| Sep 2017 | - | $203.27 M(-7.4%) |
| Jun 2017 | - | $219.55 M(-7.0%) |
| Mar 2017 | - | $236.17 M(-5.7%) |
| Dec 2016 | $250.58 M(+274.4%) | $250.58 M(-7.2%) |
| Sep 2016 | - | $270.07 M(-4.0%) |
| Jun 2016 | - | $281.29 M(+411.6%) |
| Mar 2016 | - | $54.98 M(-17.9%) |
| Dec 2015 | $66.93 M(+760.8%) | $66.93 M |
| Dec 2014 | $7.78 M | - |
FAQ
- What is Intellia Therapeutics annual working capital?
- What is the all time high annual working capital for Intellia Therapeutics?
- What is Intellia Therapeutics annual working capital year-on-year change?
- What is Intellia Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Intellia Therapeutics?
- What is Intellia Therapeutics quarterly working capital year-on-year change?
What is Intellia Therapeutics annual working capital?
The current annual working capital of NTLA is $883.12 M
What is the all time high annual working capital for Intellia Therapeutics?
Intellia Therapeutics all-time high annual working capital is $1.09 B
What is Intellia Therapeutics annual working capital year-on-year change?
Over the past year, NTLA annual working capital has changed by -$207.12 M (-19.00%)
What is Intellia Therapeutics quarterly working capital?
The current quarterly working capital of NTLA is $605.22 M
What is the all time high quarterly working capital for Intellia Therapeutics?
Intellia Therapeutics all-time high quarterly working capital is $1.09 B
What is Intellia Therapeutics quarterly working capital year-on-year change?
Over the past year, NTLA quarterly working capital has changed by -$196.32 M (-24.49%)